Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Guardian Pharmacy Services (GRDN) EBIAT (2023 - 2025)

Guardian Pharmacy Services' EBIAT history spans 3 years, with the latest figure at $20.9 million for Q4 2025.

  • For Q4 2025, EBIAT rose 290.21% year-over-year to $20.9 million; the TTM value through Dec 2025 reached $49.2 million, up 144.73%, while the annual FY2025 figure was $49.2 million, 144.73% up from the prior year.
  • EBIAT for Q4 2025 was $20.9 million at Guardian Pharmacy Services, up from $9.8 million in the prior quarter.
  • Across five years, EBIAT topped out at $20.9 million in Q4 2025 and bottomed at -$122.0 million in Q3 2024.
  • The 3-year median for EBIAT is $9.4 million (2025), against an average of -$5.1 million.
  • The largest annual shift saw EBIAT tumbled 175.55% in 2024 before it surged 290.21% in 2025.
  • A 3-year view of EBIAT shows it stood at $14.6 million in 2023, then crashed by 175.55% to -$11.0 million in 2024, then soared by 290.21% to $20.9 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's EBIAT are $20.9 million (Q4 2025), $9.8 million (Q3 2025), and $9.0 million (Q2 2025).